Skip to main content
Donate
Login
Celebrate IASLC's 50th Anniversary
Celebrate IASLC's 50th Anniversary
History
Support The Mission
Support The Mission
Partners for Thoracic Cancer Care
Legacy Society
IASLC Global Member Survey on Inclusivity
Learn About Us
Learn About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Contact
Search
Donate
Login
Conferences & Webinars
Conferences & Webinars
Upcoming Conferences & Webinars
Past Conferences & Webinars
WCLC 2024
Research & Education
Research & Education
Publications, Resources & Guidelines
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Lung Cancer 360
Research Projects
Research Projects
Staging Project
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Early-Career Opportunities
News
News
ILCN
Press Releases
Lung Cancer Considered Podcast
Membership
Membership
Become a Member
Renew Your Membership
Partner Society Membership Offers
Patient Advocacy
Patient Advocacy
STARS
Advocacy Partner Spotlight
Lung Cancer Awareness Month 2023 Highlights
Foundation
Foundation
Donor Recognition
Research Grant Program
Grant Recipient Spotlights
Research Grant Recipients
Search
Fulltext search
Fulltext search
Search
Displaying 37 - 48 items out of 561 results
ILCN article
Prolonging CT Screening Intervals is Deemed Safe in Individuals with Negative Baseline Results
ILCN article
A National Network Provides a Window into Lung Cancer Screening Trends, Successes across the United States
ILCN article
Olaparib Maintenance Did Not Improve PFS, OS in Platinum-Sensitive NSCLC
ILCN article
CheckMate 9LA Combination Effective in Advanced NSCLC Despite PD-L1 Expression, TMB Status
ILCN article
PACIFIC-R: Findings Reflect Clinical Reality of Consolidation Therapy in Stage III NSCLC
ILCN article
The Role of PORT in Patients With Completely Resected Stage III-N2 NSCLC: A Pro/Con - The Con Side
ILCN article
The Role of PORT in Patients With Completely Resected Stage III-N2 NSCLC: A Pro/Con - The Pro Side
ILCN article
Symposium Chairs Reflect on Current Status, Next Steps for Lung Cancer Screening on a Global Scale
ILCN article
NCI Launches the Cancer Moonshot SM Biobank to Accelerate Research in Cancer Treatment
ILCN article
Voice from Asia: Combination of Immune Checkpoint Inhibitors With Chemotherapy for Advanced Non-squamous NSCLC
ILCN article
ASCO and Ontario Health Publish Joint Guideline Update on Systemic Therapy for Stage IV NSCLC
ILCN article
Immunotherapy Use in Patients With Lung Cancer and Comorbidities
Pagination
First
First page
‹
Previous page
1
2
3
4
5
6
7
8
9
…
›
Next page
Last
Last page